MetLife Investment Management, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 104 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$689,316
+0.6%
97,3610.0%0.01%0.0%
Q2 2023$685,421
-15.6%
97,3610.0%0.01%
-16.7%
Q1 2023$811,991
-27.4%
97,3610.0%0.01%
-33.3%
Q4 2022$1,117,704
-8.9%
97,3610.0%0.01%
-18.2%
Q3 2022$1,226,749
+19.1%
97,3610.0%0.01%
+37.5%
Q2 2022$1,030,079
-34.9%
97,3610.0%0.01%
-20.0%
Q1 2022$1,583,090
+84.3%
97,361
+57.0%
0.01%
+42.9%
Q4 2021$858,894
-3.6%
62,0140.0%0.01%
-12.5%
Q3 2021$891,141
-17.3%
62,014
-9.0%
0.01%
-20.0%
Q2 2021$1,077,926
+55.5%
68,1800.0%0.01%
+42.9%
Q1 2021$693,391
+27.8%
68,180
-6.4%
0.01%
+16.7%
Q4 2020$542,733
+125.5%
72,850
+4.0%
0.01%
+100.0%
Q3 2020$240,728
-27.9%
70,0810.0%0.00%
-25.0%
Q2 2020$333,936
+327.1%
70,081
+79.3%
0.00%
+300.0%
Q1 2020$78,178
-67.8%
39,089
-44.5%
0.00%
-66.7%
Q4 2019$243,049
+67.7%
70,449
+39.3%
0.00%
+50.0%
Q3 2019$144,935
-24.4%
50,5880.0%0.00%0.0%
Q2 2019$191,729
-53.4%
50,5880.0%0.00%
-60.0%
Q1 2019$411,786
+0.9%
50,5880.0%0.01%0.0%
Q4 2018$408,245
+5.8%
50,5880.0%0.01%
+25.0%
Q3 2018$385,986
+56.9%
50,588
+18.0%
0.00%
+33.3%
Q2 2018$246,000
+20.0%
42,8810.0%0.00%
+50.0%
Q1 2018$205,000
-2.8%
42,8810.0%0.00%0.0%
Q4 2017$211,00042,8810.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders